SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-023205
Filing Date
2021-02-16
Accepted
2021-02-16 09:48:45
Documents
1
Group Members
HEIGHTS CAPITAL MANAGEMENT

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm216476d15_sc13ga.htm SC 13G/A 56303
  Complete submission text file 0001104659-21-023205.txt   57983
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Subject) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-59335 | Film No.: 21633596
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 345-949-8080
CVI Investments, Inc. (Filed by) CIK: 0001649553 (see all company filings)

IRS No.: 981253664 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A